1. Introduction {#sec1-ijms-19-00814}
===============

Human cardiac fibroblasts (HCFs) are the highest cell population in the myocardium, accounting for approximately two-thirds of the cells \[[@B1-ijms-19-00814]\], and play a role in cardiac development, myocardial structuring, cell signaling, and electro-mechanical function in healthy and diseased myocardium \[[@B2-ijms-19-00814]\]. Although HCFs are not electrically excitable, they express a plethora of ion channels that modulate cardiac electrical function. The distribution and properties of their ion channels are distinct from those of cardiomyocytes \[[@B3-ijms-19-00814]\]. The electrical coupling between fibroblasts/myofibroblasts and ventricular cardiomyocytes has been demonstrated not only in co-culture conditions \[[@B1-ijms-19-00814],[@B4-ijms-19-00814],[@B5-ijms-19-00814]\], but also in the whole heart \[[@B6-ijms-19-00814]\]. In fact, the two types of cells can directly couple to each other via connexin-based gap junction \[[@B7-ijms-19-00814]\]. High rate of electrical activation from tachy-paced atrial cardiomyocytes induce them to secret factors into the culture medium that in turn activate fibroblasts \[[@B8-ijms-19-00814]\]. Conversely, cardiac fibroblasts paracrine factors alter impulse conduction and ion channel expression of cardiomyocytes \[[@B9-ijms-19-00814]\]. In addition, these interactions are enhanced in response to cardiac injury \[[@B10-ijms-19-00814]\].

Voltage-gated K^+^ (K~V~) currents are activated on membrane depolarization, regulation of resting membrane potential, influence the amplitudes and durations of myocardial action potentials, and the electrical coupling between the cells and cardiac fibroblasts \[[@B11-ijms-19-00814],[@B12-ijms-19-00814]\]. Mainly, two classes of K~V~ currents have been distinguished based primarily on differences in time- and voltage-dependent properties: slowly inactivating delayed rectifier K^+^ current, referred to as I~K~ and rapidly inactivating transient outward K^+^ current, I~to~, which can be differentiated by electrophysiological and pharmacological studies \[[@B3-ijms-19-00814],[@B13-ijms-19-00814],[@B14-ijms-19-00814],[@B15-ijms-19-00814]\]. The two types of K~V~ currents are also present in HCFs \[[@B3-ijms-19-00814]\] but the molecular determinants underlying I~K~ and I~to~ have not been extensively studied.

Nitric oxide (NO), a ubiquitous cellular messenger, is synthesized by essentially all cardiac cell types and plays a key role in the regulation of cardiac functions \[[@B16-ijms-19-00814],[@B17-ijms-19-00814]\], including the direct modulation of myocardial contractility \[[@B18-ijms-19-00814]\], myocardial regeneration \[[@B19-ijms-19-00814]\], hypertrophic remodeling \[[@B20-ijms-19-00814]\], and apoptosis \[[@B21-ijms-19-00814]\]. These effects of NO are related to the modulation of the activity of cardiac ion channels implicated in the generation of cardiac action potential \[[@B22-ijms-19-00814]\]. Previous reports demonstrated that NO inhibits I~K~ in mouse ventricular myocytes \[[@B23-ijms-19-00814]\], but increases this current in guinea-pig ventricular myocytes \[[@B24-ijms-19-00814]\]. In addition, NO inhibits I~to~ in human atrial and ventricular myocytes \[[@B25-ijms-19-00814]\].

NO exerts its biological effects through cyclic GMP (cGMP)-dependent and cGMP-independent signaling pathways. Specificity of cGMP signals is achieved through cGMP synthesis by soluble guanylate cyclase (sGC). In cardiomyocytes, the physiological effects of cGMP are exerted through the activation of protein kinase G (PKG). Increasing evidence suggests that cGMP-dependent signaling pathways play an important role in inhibiting cardiac remodeling and represent a promising therapeutic target for treatment of cardiovascular diseases \[[@B26-ijms-19-00814]\].

Although sGC was the first identified receptor for NO, NO exerts a ubiquitous influence in a cGMP-independent manner. NO can modulate the cAMP/protein kinase A (PKA) signaling pathway; low levels of NO increase cAMP, by activation of adenylate cyclase (AC) in rat ventricular myocytes \[[@B27-ijms-19-00814]\]. In addition, many effects of NO are mediated by *S*-nitrosylation, the covalent modification of a protein cysteine thiol by an NO group to generate an *S*-nitrosothiol that implicates in all major functions of NO in the cardiovascular system \[[@B28-ijms-19-00814],[@B29-ijms-19-00814],[@B30-ijms-19-00814]\].

However, the effects of NO on K~V~ channels of HCFs and the underlying cyclic nucleotide mechanisms remain unclear. Therefore, this study aimed to analyze the effects of NO on K~V~ channels in cultured human ventricular fibroblasts, as well as the intracellular signaling pathway responsible for these effects.

2. Results {#sec2-ijms-19-00814}
==========

2.1. Identification of Two Types of Voltage-Gated K^+^ Channels in Human Cardiac Fibroblasts by RT-PCR {#sec2dot1-ijms-19-00814}
------------------------------------------------------------------------------------------------------

In the present study, we used RT-PCR targeting human genes for K~V~ channel pore-forming α subunit in HCFs. The expressions of important genes for K~V~ currents in cardiac myocytes, the pore-forming α subunits of K~V~1 (Shaker) family, K~V~2 (Shab) family, K~V~3 (Shaw) faimly, and K~V~4 (Shal) faimly were tested \[[@B14-ijms-19-00814]\]. Strong gene expression was observed with K~V~1.1, K~V~1.2, K~V~1.5, and K~V~3.1, while weak gene expression was exhibited with K~V~1.6, K~V~1.7, and K~V~2.1 ([Figure 1](#ijms-19-00814-f001){ref-type="fig"}A). All of the products of these genes are parts of I~K~ channel. For the I~to~ channel, strong gene expression of K~V~3.3 and K~V~3.4 and weak expression of K~V~1.4, K~V~4.1, K~V~4.2, and K~V~4.4 were seen in the HCFs ([Figure 1](#ijms-19-00814-f001){ref-type="fig"}B). Gene expression of K~V~1.3, K~V~ 2.2 (for I~K~ channel) and K~V~4.3 (for I~to~ channel) were not observed in the HCFs.

2.2. Identification of Two Types of Voltage-Gated K^+^ Channels using Electrophysiological Methods {#sec2dot2-ijms-19-00814}
--------------------------------------------------------------------------------------------------

The two types of K~V~ currents with typical behavior were recorded (I~K~ and I~to~) with the whole-cell patch clamp technique. The stimulation voltage protocol consisted of depolarizing steps repeated every 10 s with a 10-mV increment for 400 milliseconds (−80 mV of holding potential). To exclude the influence of large-conductance Ca^2+^-activated K^+^ current (IBK~Ca~), which is another major K^+^ current, iberiotoxin (100 nM) was added to the bath solution and EGTA (10 mM) into the pipette solutions. These currents could be distinguished based on their activation and inactivation kinetics. I~K~ exhibited fast activation and slow or partial inactivation ([Figure 2](#ijms-19-00814-f002){ref-type="fig"}A) and I~to~ demonstrated fast activation and inactivation kinetics ([Figure 2](#ijms-19-00814-f002){ref-type="fig"}B).

I~K~ and I~to~ were detected in 82.5% (*n* = 312 of 378) and 17.5% (*n* = 66 of 378) of the cells, respectively. These currents could also be distinguished based on the effects of K^+^ current blockers. Both K~V~ currents were sensitive to 4-aminopyridine (4-AP). I~K~ was sensitive to a high concentration of 4-AP (10 mM, −39.6 ± 6.4% of the control, in steady state current at +30 mV, *n* = 4, *p* \< 0.05, [Figure 2](#ijms-19-00814-f002){ref-type="fig"}A) and I~to~ was sensitive to a lower concentration of 4-AP (1 mM, −30.7 ± 8.6% of the control, *n* = 4, *p* \< 0.05; 10 mM, −62.3 ± 7.7% of the control, in peak current at +30 mV, *n* = 4, *p* \< 0.01, [Figure 2](#ijms-19-00814-f002){ref-type="fig"}B).

On the other hand, when assessing the effects of tetraethylammonium chloride (TEA), another K^+^ channel blocker, I~K~ was inhibited at a high concentration of TEA (10 mM, −42.1 ± 9.6% of the control, *n* = 4, *p* \< 0.05, [Figure 3](#ijms-19-00814-f003){ref-type="fig"}A) but not at a low concentration of TEA (1 mM). However, I~to~ was not inhibited by 10 mM TEA (−4.5 ± 8.2% of the control, *n* = 4, [Figure 3](#ijms-19-00814-f003){ref-type="fig"}B).

2.3. Effect of NO on Two Types of Voltage-Gated K^+^ Currents {#sec2dot3-ijms-19-00814}
-------------------------------------------------------------

To determine the effect of NO on K~V~ currents in HCFs, SNAP (an NO donor, 100 µM) was added to the bath solution. The amplitude of I~K~ was significantly increased by SNAP (+46.0 ± 10.9% of the control, *n* = 6, *p* \< 0.05, [Figure 4](#ijms-19-00814-f004){ref-type="fig"}A). On the other hand, I~to~ was not activated by SNAP (+1.6 ± 9.8% of the control, *n* = 6, [Figure 4](#ijms-19-00814-f004){ref-type="fig"}B). After the addition of SNAP, the current density of I~K~ at +30 mV increased from 2.67 ± 0.70 pA/pF to 3.89 ± 0.76 pA/pF. On the other hand, the current density of I~to~ in the peak state was not altered by SNAP (2.56 ± 0.96 pA/pF to 2.60 ± 0.94 pA/pF).

Various concentrations of SNAP (0.1 to 300 µM) were applied and the I~K~ was then examined to explore whether SNAP-induced stimulation was concentration dependent ([Figure 4](#ijms-19-00814-f004){ref-type="fig"}C). I~K~ was elicited by one-step depolarizing pulses of +30 mV. The I~K~ was increased by increasing concentrations of SNAP, but the low level of NO observed in the physiologic condition did not affect the I~K~ of HCFs. Steady-state currents normalized by control data were fitted with the Hill equation, producing an EC~50~ value of 26.4 µM and a Hill coefficient of 0.96 (*n* = 7).

2.4. Effect of NO on Delayed Rectifier K^+^ Current through PKG Signaling Pathway {#sec2dot4-ijms-19-00814}
---------------------------------------------------------------------------------

NO activates sGC and produces cGMP, which activates PKG. We examined the contribution of cGMP to SNAP-induced I~K~ enhancement, using 1H-(1,2,4)oxadiazolo\[4,3-a\]quinoxalin-1-one (ODQ, a sGC blocker). When the cells were pretreated with ODQ (10 µM), I~K~ did not increase in the presence of 100 µM SNAP (--2.6 ± 9.3% of the control, *n* = 7, [Figure 5](#ijms-19-00814-f005){ref-type="fig"}A). To further confirm the contribution of the cGMP signaling pathway, KT5823 (a PKG blocker, 1 µM) was added to the bath, and SNAP then failed to increase I~K~ (+2.3 ± 6.2% of the control, *n* = 7, [Figure 5](#ijms-19-00814-f005){ref-type="fig"}B).

We also assessed the effect of cGMP, which is generated from NO binding to sGC. 8-Bromo-cyclic GMP (8-Br-cGMP, an activator of PKG, 300 µM) increased I~K~ to +84.0 ± 14.5% of the control (*n* = 4, *p* \< 0.05, [Figure 5](#ijms-19-00814-f005){ref-type="fig"}C). The current densities at +30 mV with the addition of SNAP were not altered after ODQ pretreatment (2.58 ± 0.81 pA/pF at control, 2.49 ± 0.77 pA/pF at ODQ, 2.51 ± 0.75 pA/pF at SNAP, [Figure 5](#ijms-19-00814-f005){ref-type="fig"}D) or after KT5823 pretreatment (2.39 ± 0.85 pA/pF at control, 2.47 ± 0.42 pA/pF at KT5823, 2.44 ± 0.53 pA/pF at SNAP). On the other hand, the current density with 8-Br-cGMP treatment increased significantly (from 2.40 ± 0.58 pA/pF to 4.42 ± 0.84 pA/pF).

2.5. Effect of NO on Delayed Rectifier K^+^ Current through PKA Signaling Pathway {#sec2dot5-ijms-19-00814}
---------------------------------------------------------------------------------

We examined the contribution of cAMP to SNAP-induced I~K~ enhancement, using KT5720 (a PKA blocker). When the cells were pretreated with KT5720 (1 µM) in the bath solution for 20 min, 100 µM SNAP did not increase the I~K~ (−1.1 ± 9.8% of the control, *n* = 7, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}A).

To further confirm the contribution of the cAMP signaling pathway, the cells were pretreated with SQ22536 (an AC blocker, 100 µM), 100 µM SNAP then failed to increase I~K~ significantly (+4.7 ± 11.3% of the control, *n* = 7, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}B). On the other hand, forskolin (a stimulator of AC and an activator of PKA, 10 µM) increased the amplitude of I~K~ (+20.0 ± 11.0% of the control, *n* = 6, *p* \< 0.05, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}C). 8-Bromo-cyclic AMP (8-Br-cAMP, a cell-permeable cAMP, and an activator of PKA, 300 µM) also increased the activity of I~K~ (+40.4 ± 19.2% of the control, *n* = 5, *p* \< 0.01, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}D). The current densities at +30 mV with SNAP were not altered after KT5720 pretreatment (2.35 ± 0.49 pA/pF with control, 2.13 ± 0.42 pA/pF at KT5720, 2.33 ± 0.48 pA/pF with SNAP, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}E) or after SQ22536 pretreatment (2.36 ± 0.88 pA/pF with control, 2.44 ± 0.97 pA/pF with SQ22536, 2.48 ± 0.99 pA/pF with SNAP). On the other hand, the current densities with the forskolin or 8-Br-cAMP effects on I~K~ increased significantly (2.49 ± 0.28 pA/pF with control, 2.99 ± 0.31 pA/pF with forskolin; from 2.44 ± 0.51 pA/pF to 3.42 ± 0.97 pA/pF with 8-Br-cAMP, [Figure 6](#ijms-19-00814-f006){ref-type="fig"}E).

2.6. Effect of NO on Delayed Rectifier K^+^ Current through the S-Nitrosylation Pathway {#sec2dot6-ijms-19-00814}
---------------------------------------------------------------------------------------

NO affects ubiquitous signaling pathways via posttranslational modification of cysteine residues, a reaction termed S-nitrosylation \[[@B28-ijms-19-00814]\]. To examine the involvement of S-nitrosylation in SNAP-induced I~K~ enhancement, we pretreated the cells with N-ethylmaleimide (NEM, a thiol-alkylating reagent, 0.5 mM) and then applied SNAP (100 µM). In the presence of NEM, SNAP increased I~K~ significantly (+42.3 ± 10.1% of the control, *n* = 5, *p* \< 0.05, [Figure 7](#ijms-19-00814-f007){ref-type="fig"}A), which suggests that the thiol residue was not the ultimate target of NO.

When DL-dithiothreitol (DTT, a reducing agent, 5 mM) was applied after I~K~ had been enhanced by SNAP (100 µM), it could not reverse the SNAP-induced enhancement of I~K~ (+45.5 ± 12.2% of the control with SNAP, *n* = 6, *p* \< 0.05; +45.7 ± 6.9% of the control with DTT, *n* = 6, *p* \< 0.05 for the control, [Figure 7](#ijms-19-00814-f007){ref-type="fig"}B). These findings suggest that *S*-nitrosylation is not the main mechanism for the NO stimulation of I~K~ in HCFs. [Figure 7](#ijms-19-00814-f007){ref-type="fig"}C shows the current densities with the SNAP effects on I~K~ after NEM pretreatment (2.38 ± 0.1 pA/pF with control, 2.53 ± 0.11 pA/pF with NEM, 3.39 ± 0.09 pA/pF with SNAP) and the current densities after DTT treatment following SNAP (2.38 ± 0.13 pA/pF with control, 3.40 ± 0.16 pA/pF with SNAP, 3.47 ± 0.09 pA/pF with DTT).

3. Discussion {#sec3-ijms-19-00814}
=============

In this study, we characterized the voltage-gated K^+^ (K~V~) channels in human cardiac ventricular fibroblasts and the effects of NO on the channels. We demonstrated the functional expression of two types of K~V~ channels: delayed rectifier K^+^ channel and transient outward K^+^ channel. We also observed that NO stimulated delayed rectifier K^+^ current (I~K~), but not transient outward K^+^ current (I~to~), through the sGC/cGMP/PKG pathway and AC/cAMP/PKA pathway, but not through *S*-nitrosylation.

3.1. Identification of Two Types of Kv Channels in Human Cardiac Fibroblasts by Molecular Methods {#sec3dot1-ijms-19-00814}
-------------------------------------------------------------------------------------------------

The electrophysiological properties of cardiac cells are determined by the composition of ion channels and by their absolute abundance and proportional ratio. In healthy human hearts, the significant expression levels of K~V~1.2, K~V~1.5, K~V~1.7, K~V~2.1, and K~V~3.1 (for the I~K~) and K~V~1.4, K~V~3.3, K~V~3.4, K~V~4.1, and K~V~4.3 (for the I~to~) are found \[[@B31-ijms-19-00814]\], which might indicate a functional role of these ion channel subunits in the formation of action potential in the human atrium and ventricle. K~V~1.5 is thought to be the major contributor to the I~K~ in human heart \[[@B23-ijms-19-00814],[@B32-ijms-19-00814]\] and K~V~4.3 is responsible for the I~to~ \[[@B25-ijms-19-00814],[@B33-ijms-19-00814],[@B34-ijms-19-00814]\]. However, very little is known about the expression of K^+^ channel subunits in human cardiac fibroblasts.

In our RT-PCR analysis of mRNA expression of K~V~ channel genes in HCFs, there was a strong mRNA expression of K~V~1.1, K~V~1.2, K~V~1.5, and K~V~3.1 and a weak expression of K~V~1.6, K~V~1.7, and K~V~2.1 (for the I~K~). We also found that a strong mRNA expression of K~V~3.3 and K~V~3.4, and a weak expression of K~V~1.4, K~V~4.1, K~V~4.2, and K~V~4.4 (for the I~to~).

These results differed from those of a previous report on K~V~ channels in HCFs \[[@B3-ijms-19-00814]\]. In that report, the investigators found RT-PCR products corresponding to significant gene expression of K~V~1.5 and K~V~1.6 (for the I~K~) and K~V~4.2 and K~V~4.3 (for the I~to~), but found none for K~V~2.1 and K~V~3.1 (for the I~K~) or for K~V~1.4 (for the I~to~). The reason for the discrepancy in our results is unclear.

The K~V~4.3 represents the predominant K^+^ channel subunit underlying I~to~ in human cardiomyocytes, as the most abundant K^+^ channel mRNAs were K~V~4.3 (80.7%) \[[@B35-ijms-19-00814]\], but in our HCFs experiments, K~V~4.3 mRNA was not detected. To confirm our RT-PCR results for the K~V~ channels in HCFs, we repeated the RT-PCR several times to measure the gene expression of K~V~4.3 for the I~to~, but we found no gene expression.

Changes in the expression of K^+^ channels explain the regional variations in morphology and duration of cardiac action potential among different cardiac regions and are influenced by heart rate, intracellular signaling pathways, drug and cardiovascular disorders \[[@B36-ijms-19-00814]\]. Further investigations using molecular and electrophysiological approaches are needed to reveal the basis of ionic currents in cardiac fibroblasts in different heart regions because the extensive networks exist between cardiac fibroblasts and cardiomyocytes, that make the heterocellular electrical coupling \[[@B2-ijms-19-00814],[@B4-ijms-19-00814],[@B37-ijms-19-00814],[@B38-ijms-19-00814],[@B39-ijms-19-00814]\].

3.2. Identification of Voltage-Gated K^+^ Channels in Human Cardiac Fibroblasts via Electrophysiological Methods {#sec3dot2-ijms-19-00814}
----------------------------------------------------------------------------------------------------------------

In our results, among the two types of K~V~ currents that could be distinguished by their activation and inactivation kinetics, I~K~ was the main subtype of K~V~ currents in HCFs, as I~K~ was recorded in 82.5% of HCFs with the whole-cell patch-clamp technique. This result was consistent with previous reports \[[@B11-ijms-19-00814],[@B40-ijms-19-00814],[@B41-ijms-19-00814]\], but was somewhat discrepant with the results found by Li et al. \[[@B3-ijms-19-00814]\].

According to their report on K^+^ currents in HCFs, IBK~Ca~ was present in most HCFs (88%), and I~K~ and I~to~ were equally present but in smaller populations (15% and 14%, respectively).

The two types of K~V~ currents were 4-AP sensitive in HCFs and these results are consistent with others \[[@B15-ijms-19-00814],[@B42-ijms-19-00814],[@B43-ijms-19-00814],[@B44-ijms-19-00814]\]. I~to~ was more sensitive than I~K~ to 4-AP, and similar results were found with human atrial I~to~ \[[@B35-ijms-19-00814]\]. However, for TEA, another K^+^ channel blocker, the K~V~ currents showed different responses: a high concentration of TEA (10 mM) inhibited I~K~ (−42%) but not I~to~. In a study of human ventricular myocytes, I~K~ was not very sensitive to TEA: that is, the reduction was \<20% with 10 mM external TEA \[[@B44-ijms-19-00814]\]. On the other hand, 1 mM TEA could not inhibit either K~V~ current, consistent with previous reports: that is, low concentrations of TEA (≤1 mM) predominantly blocked Ca^2+^-activated K^+^ (K~Ca~) currents \[[@B45-ijms-19-00814],[@B46-ijms-19-00814],[@B47-ijms-19-00814]\].

3.3. Effect of NO on Two Types of Voltage-Gated K^+^ Currents {#sec3dot3-ijms-19-00814}
-------------------------------------------------------------

We demonstrated that NO produced a concentration-dependent stimulation of I~K~ in HCFs, and these results were consistent with other reports in guinea-pig cardiomyocytes \[[@B24-ijms-19-00814],[@B48-ijms-19-00814]\]. While a low concentration of NO (0.1--1 µM SNAP) did not affect the I~K~ of HCFs, a high concentration of NO (100 µM SNAP) increased the amplitude of I~K~ with an EC~50~ of approximately 26.4 µM in our experiment. In previous study, NO inhibited the hKv1.5 channel current, which generates I~K~ in transfected Chinese hamster ovary (CHO) cells and mouse ventricular myocytes \[[@B23-ijms-19-00814]\].

This discrepancy could be explained by the concentration difference, because the effect of NO on cell function is determined by its concentration. Lower levels of NO (0.1--1 µM SNAP), which are observed under physiologic conditions, led to concentration-dependent inhibition of hKv1.5 current in cardiac myocytes \[[@B27-ijms-19-00814]\], with the IC~50~ being approximately 340 nM \[[@B23-ijms-19-00814]\]. Higher levels of NO (100 µM SNAP), which are observed in pathologic states, increased I~K~ \[[@B49-ijms-19-00814],[@B50-ijms-19-00814]\].

We also demonstrated that NO could not affect I~to~ in HCFs; however, in previous study, NO inhibited K~V~4.3 in transfected CHO cells and I~to~ in human atrial and mouse ventricular myocytes in a concentration and voltage-dependent manner with an IC~50~ of 375 nM \[[@B25-ijms-19-00814]\]. These differences could be explained by differences in the cell type and expressed K^+^ channel mRNA \[[@B36-ijms-19-00814]\].

3.4. Effect of NO on Delayed Rectifier K^+^ Current through Protein Kinases Signaling Pathways and S-Nitrosylation {#sec3dot4-ijms-19-00814}
------------------------------------------------------------------------------------------------------------------

In our results, the stimulating effect of NO on I~K~ was suppressed in the presence of sGC inhibitor (ODQ) or PKG inhibitor (KT5823), and I~K~ was increased by 8-Br-cGMP, a cell-permeable analogue of cGMP. These results suggest that the stimulatory effects of NO are dependent on the sGC/cGMP/PKG pathway in HCFs. In previous reports, the cGMP-dependent pathway was suggested to play a principal role in NO action on hKv1.5-induced I~K~ in guinea-pig cardiomyocytes \[[@B24-ijms-19-00814]\] and sinoatrial nodal cells \[[@B48-ijms-19-00814]\].

We also investigated the effects of the AC/cAMP/PKA pathway on K~V~ currents in HCFs, because the PKA pathway is also responsible for NO-mediated cardioprotection \[[@B51-ijms-19-00814]\], NO can directly activate AC and thereby increase cAMP levels \[[@B27-ijms-19-00814]\], and AC activators or membrane-permeable cAMP analogs can increase NO production \[[@B52-ijms-19-00814]\]. We found that specific PKA blockers (KT5720 or SQ22536) inhibited the stimulating effect of NO for I~K,~ and forskolin (an AC activator), and 8-Br-cAMP (a membrane-permeable cAMP) increased the currents in HCFs.

These results indicate that NO (100 µM SNAP) increased I~K~ of HCFs through AC/cAMP/PKA signaling mechanisms. It has been reported that NO also modulates cardiac IBK~Ca~ channels, which are also important K^+^ channels in HCFs \[[@B13-ijms-19-00814]\], and Na^+^ channels in guinea pig and mouse ventricular myocytes through the cAMP and cGMP pathways \[[@B53-ijms-19-00814]\].

We also examined whether NO increased I~K~ through a cGMP-independent pathway, a direct *S*-nitrosylation of the thiol residue of target proteins, which is a well-known alternative pathway for the biological effects of NO \[[@B23-ijms-19-00814],[@B24-ijms-19-00814],[@B25-ijms-19-00814],[@B29-ijms-19-00814]\]. *S*-nitrosylation regulates many cardiac ion channels and modulates the major currents involved in the generation of the action potential in cardiomyocytes \[[@B28-ijms-19-00814]\]. Inwardly rectifying K^+^ current that determine resting membrane potential is also expressed in rat ventricular fibroblasts \[[@B3-ijms-19-00814]\] and human ventricular fibroblasts \[[@B3-ijms-19-00814]\]. NO increases the current by nitrosylation in cardiomyocytes and transfected CHO cells with Kir2.1 channel (the major isoform of inwardly rectifying K^+^ channel) \[[@B54-ijms-19-00814]\].

It has been reported that *S*-nitrosylation increases I~K~ in guinea pig cardiomyocytes \[[@B55-ijms-19-00814]\], but inhibits these currents in human atria \[[@B23-ijms-19-00814]\]. However, in our results, the stimulating effect of NO on I~K~ was not blocked by NEM pretreatment in HCFs. In addition, the reducing reagent DTT did not reverse NO-induced I~K~ enhancement. These results suggest that *S*-nitrosylation is not involved in NO effects on I~K~ in HCFs.

In summary, we provide evidence to demonstrate that NO modulates cardiac I~K~ but not I~to~ via a second messenger pathway through activation of PKG and PKA. This modulation occurs at a relatively high concentration of NO that was observed in pathological states. Therefore, it is reasonable to speculate that the modulation of I~K~ by NO may play a significant functional role in the pathological states.

4. Materials and Methods {#sec4-ijms-19-00814}
========================

4.1. Cell Preparation and Culture {#sec4dot1-ijms-19-00814}
---------------------------------

Commercially available primary adult human ventricular cardiac fibroblasts (HCF-av, Catalogue \#6310 from ScienCell, Carisbad, CA, USA) were used. These cells were used for many bimolecular and electrophysiological experiments \[[@B3-ijms-19-00814],[@B13-ijms-19-00814],[@B40-ijms-19-00814],[@B56-ijms-19-00814],[@B57-ijms-19-00814],[@B58-ijms-19-00814]\] and confirmed as fibroblasts by discoidin domain receptor 2 staining \[[@B58-ijms-19-00814]\]. The cells were cultured in Dulbecco's modified eagle's medium (DMEM; Welgene, Gyeongsan, Gyeongsangbuk-do, Korea) that was supplemented with fetal bovine serum (10%, Welgene) and a penicillin-streptomycin solution (100×; GenDEPOT, Barker, TX, USA) in a humidified atmosphere of 5% CO~2~ and 95% air at 37 °C. Confluent fibroblasts were detached by incubation with trypsin (0.25%, Welgene) and ethylene diamine tetraacetic acid (0.02%) in DMEM for several minutes. The detached cells were pelleted by centrifugation, the supernatant was removed, and the pellet was suspended in 1 mL of bath solution. The cells used in this study were from early passages (3 to 7) to limit possible variation due to culture.

4.2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) {#sec4dot2-ijms-19-00814}
-------------------------------------------------------------

mRNA was generated using the RT-PCR technique with the primers indicated in the [Table 1](#ijms-19-00814-t001){ref-type="table"} and [Table 2](#ijms-19-00814-t002){ref-type="table"}. Total RNA was extracted from HCFs using the Total RNA Isolation PureLink RNA Mini Kit (Ambion, Carlsbad, CA, USA). First-strand cDNA was prepared with the SuperScript III Cells Direct cDNA Synthesis Kit (Invitrogen, Tokyo, Japan). Reverse transcription was performed in a S1000 Thermal Cycler (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. RT-PCR reaction products (cDNA) were resolved by 1.2% agarose gel electrophoresis and stained with ethidium bromide for visualization under ultraviolet light.

4.3. Electrophysiological Recordings {#sec4dot3-ijms-19-00814}
------------------------------------

Recordings were obtained, using a whole-cell patch clamp with an Axopatch 200B Patch Clamp Amplifier (Axon Instruments, Union City, CA, USA) at room temperature. The pCLAMP 9.0 software (Axon Instruments) was used for data acquisition and analysis of whole-cell currents. Activated currents were filtered at 2 kHz and digitized at 10 kHz. Recording patch pipettes were prepared from filament-containing borosilicate tubes (TW150F-4; World Precision Instruments, Sarasota, FL, USA), using a two-stage microelectrode puller (PC-10; Narishige, Tokyo, Japan), and were then fire polished on a microforge (MF-830; Narishige). When filled with pipette solution, the pipettes exhibited a resistance of 2--3 MΩ.

The bath solution to record K~V~ currents contained (in mM): 150 NaCl, 5.4 KCl, 1 CaCl~2~, 1 MgCl~2~, 10 glucose, and 5 HEPES (pH adjusted to 7.35 with NaOH). The pipette solution contained (in mM): 130 KCl, 1 CaCl~2~, 2 MgCl~2~, 10 HEPES, 10 EGTA, and 2 Mg-ATP (pH adjusted to 7.3 with KOH). TEA, 4-AP, SNAP, KT5823, ODQ, 8-Br-cGMP, KT5720, SQ22536, 8-Br-cAMP, and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).

4.4. Statistical Analysis {#sec4dot4-ijms-19-00814}
-------------------------

Statistical analysis was performed using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA). Results were presented as mean ± standard error of the mean (SEM). The paired Student's *t*-test was used when appropriate to evaluate the statistical significance of differences between two group means, while one-way analysis of variance (ANOVA) was used for multiple groups. *p* values \< 0.05 were considered statistically significant.
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![Identification of two types of voltage-gated K^+^ (K~V~) channels in human cardiac fibroblasts by reverse transcription polymerase chain reaction (RT-PCR). (**A**) Strong gene expression was shown for K~V~1.1, K~V~1.2 K~V~1.5, and K~V~3.1 for delayed rectifier K^+^ (I~K~) channels and (**B**) K~V~3.3 and K~V~3.4 for transient outward K^+^ (I~to~) channels~.~ Weak expression was observed for K~V~1.6, K~V~1.7 and K~V~2.1 (for I~K~) and K~V~1.4, K~V~4.1, K~V~4.2, and K~V~4.4 (for I~to~). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a positive control.](ijms-19-00814-g001){#ijms-19-00814-f001}

![Effect of 4-aminopyridine (4-AP) on K~V~ currents in HCFs. (**A**) The representative rapid activated and slow inactivated, I~K~ recorded in a single HCF in control conditions and after application of 4-AP (1 or 10 mM). The current-voltage (*I-V*) relationship of steady-state currents with I~K~ changed in the presence of 4-AP, and the concentration-response bar graphs for the 4-AP effect on I~K~ are shown. (**B**) Typical rapid-activated and inactivated I~to~ in control and after 4-AP (1 or 10 mM) addition. The *I-V* relationship of peak currents changed by the presence of 4-AP on I~to~ and concentration-response bar graphs are shown. \* *p* \< 0.05, \*\* *p* \< 0.01 versus the control.](ijms-19-00814-g002){#ijms-19-00814-f002}

![Effect of tetraethylammonium chloride (TEA) on K~V~ currents in HCFs. (**A**) The representative I~K~ recorded in a single HCF in control conditions and after application of TEA (1 or 10 mM) are shown. The *I-V* relationship of the steady-state current change of I~K~ by TEA and bar graphs for concentration change are also shown. (**B**) The typical I~to~ was not changed by TEA. The *I-V* relationship of the peak current change for the TEA of I~to~ and bar graph for concentration response are shown. \* *p* \< 0.05 versus the control.](ijms-19-00814-g003){#ijms-19-00814-f003}

![Effect of nitric oxide (NO) on two subtypes of K~V~ currents. Raw data and the *I-V* relationship of steady-state currents changed by the presence of SNAP on (**A**) delayed rectifier K^+^ current (I~K~) and (**B**) transient outward K^+^ current (I~to~). (**C**) The concentration-response curve of S-nitroso-N-acetylpenicillamine (SNAP) on I~K~. The continuous line represents the fit to the Hill equation. The normalized currents (percent inhibition) were calculated from the I~K~ in the absence of SNAP and plotted against various concentrations of SNAP. \* *p* \< 0.05 versus the control.](ijms-19-00814-g004){#ijms-19-00814-f004}

![Effects of the PKG pathway on the stimulating effect of NO on I~K~. Representative currents showing the effect of SNAP on I~K~ after pretreatment with (**A**) 1H-(1,2,4)oxadiazolo\[4,3-a\]quinoxalin-1-one (ODQ) or (**B**) KT5823. (**C**) Effect of 8-Br-cyclic GMP on I~K~. (**D**) Bar graph summarizing current density changes for the effects of SNAP on I~K~ after pre-incubation with ODQ or KT5823, and the effect of 8-Br-cyclic GMP on I~K~ current. \* *p* \< 0.05 versus the control.](ijms-19-00814-g005){#ijms-19-00814-f005}

![Effects of the protein kinase A (PKA) pathway on the stimulating effect of NO on I~K~ current. Representative currents showing the effect of SNAP on I~K~ after pretreatment with (**A**) KT5720 or (**B**) SQ22536. Effect of (**C**) forskolin or (**D**) 8-Br-cyclic AMP on I~K~. (**E**) Bar graph summarizing current density changes for the effects of SNAP on I~K~ after pre-incubation with KT5720 or SQ22536, and the effect of forskolin or 8-Br-cAMP on I~K~. \* *p* \< 0.05, \*\* *p* \< 0.01 versus the control.](ijms-19-00814-g006){#ijms-19-00814-f006}

![Influence of *S*-nitrosylation on the stimulating effect of NO on I~K~. (**A**) Representative currents showing the effect of SNAP on I~K~ after pretreatment with N-ethylmaleimide (NEM). (**B**) Effect of DL-dithiothreitol (DTT) on SNAP-stimulating I~K~. (**C**) Bar graph summarizing current density changes for SNAP effects on I~K~ after pretreatment with NEM and DTT. \* *p* \< 0.05 versus the control.](ijms-19-00814-g007){#ijms-19-00814-f007}
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###### 

Primers of delayed rectifier potassium channels used for RT-PCR.

  Gene      Forward Primer                  Reverse Primer                  Size
  --------- ------------------------------- ------------------------------- ------
  GAPDH     5′-AGCCACATCGCTCAGACACC-3′      5′-GTACTCAGCGGCCAGCATCG-3       302
  K~V~1.1   5′-CCATCATTCCTTATTTCATCAC-3     5′-CTCTTCCCCCTCAGTTTCTC-3′      488
  K~V~1.2   5′-TCCGGGATGAGAATGAAGAC-3′      5′-TTGGACAGCTTGTCACTTGC-3′      747
  K~V~1.3   5′-TCTGCCTATGCCCTTGTTTT-3′      5′-TTCCTCCCAGGATGTACTGC-3′      259
  K~V~1.5   5′-TGCGTCATCTGGTTCACCTTCG-3′    5′-TGTTCAGCAAGCCTCCCATTCC-3′    906
  K~V~1.6   5′-TCAACAGGATGGAAACCAGCCC-3′    5′-CTGCCATCTGCAACACGATTCC-3′    608
  K~V~1.7   5′-CTTCCAGGGGCATGTTATTT-3′      5′-CTCAATGGAACTCAATTCAG-3′      300
  K~V~2.1   5′-ACAGAGCAAACCAAAGGAAGAAC-3′   5′-CACCCTCCATGAAGTTGACTTTA-3′   383
  K~V~2.2   5′-AACGAACTGAGGCGAGAG -3′       5′-ACTCCGCCTAAGGGTGAAAC-3′      546
  K~V~3.1   5′-AACCCCATCGTGAACAAGACGG-3′    5′-TCATGGTGACCACGGCCCA-3′       550
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###### 

Primers of transient outward potassium channels used for RT-PCR.

  Gene      Forward Primer                 Reverse Primer                 Size
  --------- ------------------------------ ------------------------------ ------
  GAPDH     5′-AGCCACATCGCTCAGACACC-3′     5′-ATCATTCAACAACCCACCAT-3′     302
  K~V~1.4   5′-TGGCGGCTACAGTTCAGTCC-3′     5′-TGTTGACAATGACGGGCACAGG-3′   571
  K~V~3.3   5′-TTCTGCCTGGAAACCCATGAGG-3′   5′-TGCCAAATCCCAAGGTCTGAGG-3′   694
  K~V~3.4   5′-TTCAAGCTCACACGCCACTTCG-3′   5′-TTCTTTCGGTCCCGATAC-3′       656
  K~V~4.1   5′-ATCTCGAGGAGATGAGGTTC-3′     5′-GATCCGCACGGCACTGTTTC-3′     318
  K~V~4.2   5′-ATCTTCCGCCACATCCTGAA-3′     5′-GATCCGCACGGCACTGTTTC-3′     362
  K~V~4.3   5′-GATGAGCAGATGTTTGAGCAG-3′    5′-AGCAGGTGGTAGTGAGGCC-3′      106
  K~V~4.4   5′-AGCCAAGAAGAACAAGCTG-3′      5′-AGGAAGTTTAGGACATGCC-3′      315
